Vaccinations Among Adults

This topic area covers statistics and information relating to uptake of vaccinations among adults in Hull including local strategic need and service provision. Further information relating to Screening and Vaccinations Among Children and Young People is available within Health Factors within Children and Young People. There is a separate section for Screening and the NHS Health Checks under Prevention under Adults.

This page contains information from the Office for Health Improvement & Disparities’ Fingertips. Information is taken ‘live’ from the site so uses the latest available data from Fingertips and displays it on this page. As a result, some comments on this page may relate to an earlier period of time until this page is next updated (see review dates at the end of this page).

Headlines

• There are a large number of vaccinations available to infants and children. However, there are a small number of vaccinations that are offered to children and adults who are at risk owing to their personal circumstances, and other vaccinations are available to older people.
• The uptake rate for the influenza vaccine has been steadily falling in Hull since 2010/11. In 2019/20, the uptake rate in Hull reached a new low of 41.3% for at risk groups and 69.7% for people aged 65+ years. However, following the COVID-19 pandemic and more awareness and focus on the importance of having the influenza vaccine, uptake rates increased sharply to a high of 51.1% for at risk groups and 80.8% among people aged 65+ years. However, the momentum gained during and after the pandemic has subsided, and the rates have fallen.
• During 2023/24, 37.4% of people in the at risk group had their flu vaccination which was the lowest percentage in the last 14 years. Almost three-quarters (74.5%) of those aged 65+ years had their flu vaccination in 2023/24, and whilst rates had fallen in the last two years the latest rate was higher than pre-pandemic levels. The rates are lower in Hull compared to England for at risk groups (41.4%) and among those aged 65+ years (77.8%).
• Around 31,342 people at risk and 12,492 people aged 65+ years did not have their flu vaccination during 2023/24.
• The uptake for the pneumococcal polysaccharide vaccine (PPV) among those aged 65+ years was slightly lower in Hull compared to England (69.2% versus 71.8%) for 2022/23. The rate has been steadily decreasing in Hull from 74.8% for 2010/11 to 69.1% in 2019/20. The rates only marginally improved following the pandemic, and the rate in 2022/23 is similar to what it was prior to the pandemic. Around 14,939 people aged 65+ years did not have their PPV vaccine during 2022/23.
• Slightly fewer people aged 71 years in Hull in 2022/23 had had their shingles vaccination compared to England (47.5% versus 48.3%). Around 1,250 people aged 70 years did not have their shingles vaccine during 2022/23.
• The uptake rates for 2020/21 have been influenced by the COVID-19 pandemic particularly those for influenza. Furthermore, the flu vaccination programme was extended for 2021/22. People aged 50+ years (including those who will be 50 by the 31 March 2022) were eligible for the flu vaccination as well as specific ‘at risk’ groups including pregnant women. Carers and people who live with ‘at risk’ individuals were also eligible for the flu vaccination.

The Population Affected – Why Is It Important?

Specific vaccines are offered to children, young people, pregnant women, older people and other people with specific long-term health conditions. All children are offered vaccines against key diseases to prevent them getting serious diseases that can kill or cause long-term health consequences. A small number of vaccines are just offered to a selected group of children and adults who are at risk owing to their personal circumstances. Older people and other at risk groups are offered the seasonal influenza vaccination to reduce the likelihood of influenza. The pneumococcal polysaccharide vaccine (PPV) is also available to people aged 65+ years and at risk groups which protects against pneumococcal infections (protecting against 23 types of Streptococcus pneumoniae bacterium).

The ‘at risk’ groups differ depending on the disease but for the influenza vaccination the at risk group are people aged 6 months and older with chronic respiratory, heart or kidney diseases, chronic neurological conditions, diabetes, and people with a weaken immune system as a result of HIV and AIDs, or medicines such as chemotherapy, or who are seriously overweight with a body mass index of 40 or more. The flu vaccine is also available to pregnant women, and can also include other groups such as people living in long-stay residential or care homes, and those who receive carer’s allowance. Front line health and social care workers are also eligible for the influenza vaccination. It is anticipated that more people are likely to get flu in the winter of 2021/22 as fewer people will have built up natural immunity to it during the COVID-19 pandemic due to increased social distancing. The flu programme was extended in 2021/22 to include those aged 50+ years.

There is also a vaccine for shingles offered to people aged 70 years or older. Anyone previously eligible who has missed out on their vaccination remains eligible until their 80th birthday.

There are also some other vaccinations that are offered to a small number of individuals based on their circumstances. These include the BCG vaccine (Bacillus Calmette-Guerin) to protect against tuberculosis, and vaccinations for hepatitis B and chickenpox.

For certain vaccinations, generally only one dose is required (such as for shingles and the pneumococcal polysaccharide vaccine) and for others the vaccination is required every year (such as for influenza). The majority of the vaccinations given in childhood require one or a small number of doses over time and last a long time or a lifetime, although boosters are sometimes given such as a tetanus vaccination following an injury which could result in an infection, or the pneumococcal polysaccharide vaccine which may be required every five years for some people with specific health conditions.

Where sufficient numbers of people have the vaccine, it can also prevent the disease spreading in the community, and sometimes even getting rid of diseases in the community entirely. This is important for the small number of people who cannot have a vaccine for other health reasons.

It is estimated that vaccines prevent up to three million deaths worldwide very year. Since vaccines were introduced to the UK, diseases like smallpox, polio and tetanus that used to kill or disable millions of people are either gone or seen very rarely. Other diseases like measles and diphtheria have been reduced by up to 99.9% since their vaccines were introduced.

Vaccination and immunisation are often used interchangeable, but are different. Vaccination is the process of introducing the vaccination and immunisation is what is achieved.

Further information on the measles, mumps and rubella (MMR) vaccination and its protection against measles for both adults and children can be found at https://hull-mmr.co.uk

The Hull Picture

The Office for Health Improvement & Disparities’ Fingertips provide information on the uptake rates for vaccinations for adults for flu, the pneumococcal polysaccharide vaccine and for shingles. Information relating to the COVID-19 vaccination can be found on the official UK Government website for coronarvirus.

COVID-19 Vaccination

Information on the uptake of the COVID-19 vaccinations can be found on the official UK Government Health Security Agency Data Dashboard’s https://ukhsa-dashboard.data.gov.uk. It possible to Filter Results By Location and select COVID-19. The percentage uptake is based on the population registered with local GPs who live in Hull (which might be an overestimate) so it is likely that the actual percentage coverage within Hull’s population could be slightly higher than the percentage quoted. Further information relating to COVID-19 can be found within Coronavirus (COVID-19) within Health Factors under Adults.

Flu Vaccination

For 2023/24, the uptake rate for the flu vaccination was statistically significantly lower in Hull compared to England for people who were most at risk (37.4% versus 41.4%) and among those aged 65+ years (74.5% versus 77.8%).

The percentage uptake of the flu vaccination among people at risk was around 50% between 2010/11 and 2014/15, but fell sharply to 43% in 2015/16, and whilst the rate increased to 47% in 2017/18, the rate has fallen again to a new low of 41% in 2019/20. However, following the COVID-19 pandemic, there has been more focus and a national and local push around people having their flu vaccination, and the rate has increased to the highest it has been for the last decade, increasing to 51% for 2021/22. The momentum gained during the pandemic has waned though, and the percentage uptake for the flu vaccination among people at risk was the lowest it has been in the last 14 years standing at 37% for 2023/24.

Overall, 18,725 people had the vaccination during 2023/24 out of 50,067 people who were at an increased risk of illness following if they caught flu. This does mean around 31,342 people did not have their flu vaccination among those at risk.

Almost three-quarters of people aged 65+ years had their flu vaccination in 2011/12, but the rate has fallen since then and was generally just over 70% between 2013/14 and 2017/18. For both 2018/19 and 2019/20, the rate decreased to just under 70%. Following the COVID-19 pandemic with a greater push of people receiving vaccinations for flu and COVID-19, the rate has increased sharply to around eight in ten people aged 65+ years being vaccinated against flu for both 2020/21 and 2021/22. However, the uptake rate fell has subsequently fallen to 75%, although the rate is still above pre-pandemic levels.

A total of 36,495 people in Hull aged 65+ years had their flu vaccination during 2023/24 out of 48,987 individuals aged 65+ years. This does mean around 12,492 people did not have their flu vaccination among those aged 65+ years.

Pneumococcal Polysaccharide Vaccine

The pneumococcal polysaccharide vaccine (PPV) uptake in Hull was statistically significantly lower in Hull than the uptake in England for 2022/23 (69.2% versus 71.8%).

There has been a steady decline in the uptake in Hull of the PPV vaccine among those aged 65+ years falling from 75% in 2010/11 to 69% in 2019/20. In contrast, the uptake rate across the region has remained relatively unchanged and whilst there has been a reduction in England, the rate has fallen by 1.5 percentage points (compared to 5.7 percentage points in Hull). The uptake rate in Hull for 2019/20 was the lowest it has been since 2010/11.

There has been an increase between 2019/20 and 2020/21 which may be associated with the COVID-19 pandemic, although the increase is relatively small and does little to offset the decreases that occurred over the period 2010/11 to 2019/20.

A total of 33,565 people in Hull aged 65+ years had their PPV vaccine during 2022/23 out of 48,504 individuals aged 65+ years. This does mean around 14,939 people did not have their PPV vaccine among those aged 65+ years.

Shingles Vaccine

In the first five years of the shingles vaccination programme (2013/14 to 2017/18), the vaccine was routinely offered to adults aged between 70 years and 80 years on the 1 September as part of the catch-up campaign. For all subsequent years up to 2017, the routine cohort was those aged 70 on 1 September. People who were aged 71 to 78 on 1 September 2013 are being offered the shingles vaccination through a phased catch-up programme conducted over a number of years.

In April 2017, eligibility criteria for the shingles vaccination were revised so that adults become eligible for the routine programme on their 70th birthday and remain eligible until their 80th birthday. This has meant that the way in which the uptake rate is calculated has had to be changed, and the current uptake rate cannot be compared with the previous uptake rate. The uptake rate is measured in on the Office for Health Improvement & Disparities’ Fingertips as the percentage of adults turning 71 between 1 April and 31 March who have received the shingles vaccination by the end of the following June.

During 2022/23, the uptake rate for the shingles vaccination in Hull was similar to England (47.5% versus 48.3%).

A total of 1,131 people in Hull aged 70 years had their shingles vaccine during 2022/23 out of 2,381 individuals aged 65+ years. This does mean around 1,250 people did not have their shingles vaccine among those aged 70 years.

Overall, 2,381 people who had their 71st birthday between 1 April 2022 and 31 March 2023, 1,131 (47.5%) had received their shingles vaccination by June 2023. There has been an improvement in the uptake rate from 44.9% in 2018/19 to 47.0% in 2019/20 in Hull, and whilst the rate fell to 35.6% in 2020/21 likely associated with the COVID-19 pandemic, the rate increased in 2021/22 and remained the same for 2022/23. The rate is at its highest level (since 2018/19).

Strategic Need and Service Provision

If people stop having vaccines, it is possible for infectious diseases to quickly spread again. For the influenza vaccine, different strains of the disease means that the vaccine might not totally protect an individual although it is likely that the severity of infection is reduced even if it does not prevent influenza, but at a population level the number of cases of the disease are reduced provided the uptake of the vaccine is sufficiently high.

Therefore, it is important to ensure a high uptake for vaccines and thus immunisation, and in the case of the influenza vaccine that people more at risk including those aged 65+ years have the vaccine every year. This was particularly the case for the winter of 2021/22 with COVID-19 circulating. For 2021/22, the influenza vaccine coverage was extended to include Year 7 children (first year of secondary school), people living in a household which includes a vulnerable person and people aged 50+ years, although the priority is initially the most vulnerable groups (those aged 65+ years and those with a pre-existing medical condition).

It is best that a number of different strategies and approaches are used across different settings to maximise uptake for vaccines among people at high risk and among those aged 65+ years.

Further information on the measles, mumps and rubella (MMR) vaccination and its protection against measles for both adults and children can be found at https://hull-mmr.co.uk

Resources

NHS Choices: www.nhs.uk

Office for Health Improvement & Disparities’ Fingertips: https://fingertips.phe.org.uk/

The official UK government website for data and insight on coronavirus (COVID-19). https://coronavirus.data.gov.uk

Information on the measles, mumps and rubella vaccination and protection against measles for both adults and children. https://hull-mmr.co.uk

Updates

This page was last updated / checked on 24 April 2025.

This page is due to be updated / checked in November 2025.